Pluto Biosciences
PrivateLast Round
VC Round
May 13, 2025
Total Funding Raised
$4.7M
Company Overview
Pluto Biosciences operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a VC Round in May 2025.
Pluto Biosciences is a life sciences company that provides a cloud-based, collaborative platform for managing, analyzing, and visualizing complex biological data without the need for coding.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Data Visualization, Low-Code/No-Code
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluto Biosciences Comparables
Compare Pluto Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rosalind | 91% | |
| BigOmics Analytics | 88% | |
| Watershed | 87% |
For institutional investors. Book with your work email.
Pluto Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 13, 2025 | ||||
| Seed | May 2, 2023 | ||||
| Seed | Oct 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pluto Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickstart Fund | Seed, VC Round |
| Kickstart | VC Round |
| Silverton Partners | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2023
$4M round led by Silverton Partners
- Oct 12, 2021
$1M round with participation from Chris Glodé.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 4, 2026
Pluto Biosciences, Inc. launches the Pluto MCP connector in Colorado on Nov 4th '26, giving ChatGPT, Claude, Microsoft Copilot Studio, and other MCP-compatible assistants governed access to R&D programs, datasets, analyses, and results.
For institutional investors. Book with your work email.
Pluto Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pluto Biosciences's valuation, stock price, and market status.
Is Pluto Biosciences a public or private company?
Pluto Biosciences is a private company.
What is the current stock price of Pluto Biosciences?
Pluto Biosciences is a private company, so its shares have no public market price. Caplight tracks Pluto Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pluto Biosciences worth (valuation)?
Valuation information for Pluto Biosciences is not publicly available.
Can I buy Pluto Biosciences stock?
Pluto Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pluto Biosciences's last funding round?
Pluto Biosciences's most recent funding round was VC Round on May 13, 2025.
Who are the main investors in Pluto Biosciences?
Key investors in Pluto Biosciences include Kickstart Fund, Kickstart, Silverton Partners.
Will Pluto Biosciences IPO soon?
No public IPO plans have been announced for Pluto Biosciences.
How can I track Pluto Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Pluto Biosciences's shares on secondary markets.